1. Home
  2. Labeler Index
  3. Deseret Biologicals, Inc.
  4. NDC Product Code: 43742-1408 Taraxacum Officinale, Hydrastis Canadensis, Melatonin, Dopamine Hydrochloride, L-dopa, Serotonin (hydrochloride)

NDC 43742-1408 Taraxacum Officinale, Hydrastis Canadensis, Melatonin, Dopamine Hydrochloride, L-dopa, Serotonin (hydrochloride)

Liquid - View Dosage, Usage, Ingredients, Routes, UNII

Table of Contents

  1. Product Information
  2. Product Packages
  3. What is NDC 43742-1408?
  4. Active Ingredients

Product Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.
NDC Product Code:
43742-1408
Proprietary Name:
Taraxacum Officinale, Hydrastis Canadensis, Melatonin, Dopamine Hydrochloride, L-dopa, Serotonin (hydrochloride)
Non-Proprietary Name: [1]
Taraxacum Officinale, Hydrastis Canadensis, Melatonin, Dopamine Hydrochloride, L-dopa, Serotonin (hydrochloride)
Substance Name: [2]
Dopamine Hydrochloride; Goldenseal; Levodopa; Melatonin; Serotonin Hydrochloride; Taraxacum Officinale
NDC Directory Status:
Drug For Further Processing
Product Type: [3]
UNFINISHED PRODUCT INCLUDED in the NDC Directory
Dosage Form:
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Labeler Name: [5]
Deseret Biologicals, Inc.
Labeler Code:
43742
Marketing Category: [8]
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date: [9]
12-11-2018
End Marketing Date: [10]
06-03-2025
Exclude Flag: [12]
N
Unfinished Product: [13]
Yes
Code Navigator:

Code Structure Chart

Product Details

What is NDC 43742-1408?

The NDC code 43742-1408 is assigned by the FDA to the UNFINISHED product Taraxacum Officinale, Hydrastis Canadensis, Melatonin, Dopamine Hydrochloride, L-dopa, Serotonin (hydrochloride) which is drug for further processing product labeled by Deseret Biologicals, Inc.. The generic name of Taraxacum Officinale, Hydrastis Canadensis, Melatonin, Dopamine Hydrochloride, L-dopa, Serotonin (hydrochloride) is taraxacum officinale, hydrastis canadensis, melatonin, dopamine hydrochloride, l-dopa, serotonin (hydrochloride). The product's dosage form is liquid. The product is distributed in a single package with assigned NDC code 43742-1408-1 960 ml in 1 bottle, plastic . This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

What are Taraxacum Officinale, Hydrastis Canadensis, Melatonin, Dopamine Hydrochloride, L-dopa, Serotonin (hydrochloride) Active Ingredients?

An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
  • DOPAMINE HYDROCHLORIDE 8 [hp_X]/mL - One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action.
  • GOLDENSEAL 6 [hp_X]/mL
  • LEVODOPA 8 [hp_X]/mL - The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system.
  • MELATONIN 6 [hp_X]/mL - A biogenic amine that is found in animals and plants. In mammals, melatonin is produced by the PINEAL GLAND. Its secretion increases in darkness and decreases during exposure to light. Melatonin is implicated in the regulation of SLEEP, mood, and REPRODUCTION. Melatonin is also an effective antioxidant.
  • SEROTONIN HYDROCHLORIDE 8 [hp_X]/mL
  • TARAXACUM OFFICINALE 3 [hp_X]/mL - A plant genus of the family Asteraceae. Members contain chicoric and chlorogenic acids and germacrane- and eudesmane-type SESQUITERPENES.

* Please review the disclaimer below.

Product Footnotes

[1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.

[2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

[3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

[10] What is the End Marketing Date? - This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.

[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".

[13] What is an Unfinished Product? - This field indicates if the product is an unfinished drug. An unfinished drug is an active pharmaceutical ingredient either alone or with other ingredients that is not a finished drug product. Unfinished drugs are used to process other drugs or for drug compounding.